| Literature DB >> 29904717 |
Sakineh Abbasi1, Jafar Fatahi Asl2, Leila Moein Zadeh3, Mohammad Mirdoraghi4.
Abstract
The aim of the study is determining bone mineral density (BMD) of Patients with beta thalassemia in order to find the prevalence and related factors on the conditions. Z-Score of femoral neck and lumbar vertebrae were reported comparing normal matched subjects. Age and bone mineral density were significantly correlated. Moreover, the disease had significantly higher severity in men than in women. A negative significant correlation was detected between BMD and the mean of hematocrit in the last 5 years. There was significant differences between sex hormone and bone density. A significant correlation between hydroxy urea and BMD were found. A significant relationship between the use of bisphosphonates and bone density were found. Osteopenia and osteoporosis were highly prevalent in our participants. Therefore, regular tests are required to examine bone mineral density in these patients. Furthermore, the exact effect of age on bone mineral density need to be clarified.Entities:
Keywords: Ahvaz; Beta thalassemia; Bone mineral density; Osteoporosis; Z-Score
Year: 2018 PMID: 29904717 PMCID: PMC5998177 DOI: 10.1016/j.dib.2018.05.120
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Demographic features of patients (confidence interval=95%).
| Calcium+Vitamin D of consuming time to first measurement | 1/8±2/4 |
| Calcium+Vitamin D of consuming time to the second measurement time | 6/3±3 |
| Calcium+Vitamin D starting age | 22±7 |
| Age of onset of sex hormones | 15±6 |
| Duration of sex hormones to first measure | 6/3±4 |
| Duration of sex hormones to the second measure | 9/6±3 |
| Age of onset of Calcitriol | 21±7 |
| Calcitriol duration of the first measure | 2±3 |
| Calcitriol use to measure a second time | 6±3 |
| Age starting bisphosphonate | 22±7 |
| bisphosphonate use to measure of the first time | 1±2 |
| bisphosphonate use to measure a second time | 2/3±2 |
| Age starting hydroxyurea | 16/5±6 |
| hydroxyurea use to measure of the first time | 5/9±3/6 |
| hydroxyurea use to measure a second time | 6/2±3/2 |
The average of Z-Score before and after intake of drug (confidence interval=95%).
| Calcium+Vitamin D | −2/33±0/78 | –2/43±0/97 | |
| sex hormones | −2/41±0/26 | −1/91±0/11 | |
| Calcitriol duration | −1/44±0/18 | −1/98±0/36 | |
| bisphosphonate | −2/45±0/88 | −1/88±0/22 | |
| Hydroxy urea use to measure of the first time | −2/59±0/96 | −2/50±0/24 |
| Subject area | Medical Physics |
|---|---|
| More specific subject area | Describe the bone mineral density (BMD) of patients with beta thalassemia |
| Type of data | Tables |
| How data was acquired | To calculate the bone mineral density, All medical records of patients older than 15 years were reviewed. Patients demography were extracted, the results of the BMD and |
| Data format | Raw, Analyzed |
| Experimental factors | The mentioned parameters above, in abstract section, were analyzed according to the standards for |
| Experimental features | The |
| Data source location | Ahvaz province, Iran. |
| Data accessibility | The data are available whit this article |